Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Background: Artificial intelligence (AI) is used in ophthalmological disease screening and diagnostics, medical image diagnostics, and predicting late-disease progression rates. We reviewed all AI publications associated with macular edema (ME) research Between 2011 and 2022 and performed modeling, quantitative, and qualitative investigations.Methods: On 1st February 2023, we screened the Web of Science Core Collection for AI applications related to ME, from which 297 studies were identified and analyzed (2011–2022). We collected information on: publications, institutions, country/region, keywords, journal name, references, and research hotspots. Literature clustering networks and Frontier knowledge bases were investigated using bibliometrix-BiblioShiny, VOSviewer, and CiteSpace bibliometric platforms. We used the R “bibliometrix” package to synopsize our observations, enumerate keywords, visualize collaboration networks between countries/regions, and generate a topic trends plot. VOSviewer was used to examine cooperation between institutions and identify citation relationships between journals. We used CiteSpace to identify clustering keywords over the timeline and identify keywords with the strongest citation bursts.Results: In total, 47 countries published AI studies related to ME; the United States had the highest H-index, thus the greatest influence. China and the United States cooperated most closely between all countries. Also, 613 institutions generated publications - the Medical University of Vienna had the highest number of studies. This publication record and H-index meant the university was the most influential in the ME field. Reference clusters were also categorized into 10 headings: retinal Optical Coherence Tomography (OCT) fluid detection, convolutional network models, deep learning (DL)-based single-shot predictions, retinal vascular disease, diabetic retinopathy (DR), convolutional neural networks (CNNs), automated macular pathology diagnosis, dry age-related macular degeneration (DARMD), class weight, and advanced DL architecture systems. Frontier keywords were represented by diabetic macular edema (DME) (2021–2022).Conclusion: Our review of the AI-related ME literature was comprehensive, systematic, and objective, and identified future trends and current hotspots. With increased DL outputs, the ME research focus has gradually shifted from manual ME examinations to automatic ME detection and associated symptoms. In this review, we present a comprehensive and dynamic overview of AI in ME and identify future research areas.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The Export Raw Scopus Data on The Integration of Artificial Intelligence in Learning for Early Childhood Educationcontains a collection of bibliometric data extracted from the Scopus database. This dataset includes information on research publications, citation counts, author contributions, institutional affiliations, and keyword trends related to the application of artificial intelligence (AI) in early childhood education (ECE).The dataset covers studies from 2003 to 2025, providing insights into how AI has been integrated into early childhood learning environments over time. Key components of this data include:Publication Details: Title, authors, publication year, source journals, and digital object identifiers (DOI).Citation Metrics: Number of citations per article, h-index, and impact factor of sources.Author and Institutional Contributions: Leading researchers, universities, and research centers involved in AI and ECE studies.Keyword Analysis: Frequently used terms such as Artificial Intelligence, Early Childhood Education, Learning Systems, and Machine Learning, highlighting emerging research trends.Collaboration Networks: Country-wise and institutional co-authorship patterns, indicating global research collaborations.This raw Scopus export is essential for conducting bibliometric analysis, identifying research gaps, and exploring future directions in AI-driven early childhood education. It serves as a valuable resource for researchers, policymakers, and educators interested in understanding the evolution and impact of AI in early childhood learning.
Indian journal of pharmaceutical sciences Abstract & Indexing - ResearchHelpDesk - Indian Journal of Pharmaceutical Sciences (0250-474X), is the official scientific publication of the Indian Pharmaceutical Association. It started in 1939 as the Indian Journal of Pharmacy. the journal is published Bimonthly. Abstracting and Indexing Information The journal is included in the following Abstracting / Indexing services: Biosis Preview, Chemical Abstract Service (CAS), CNKI (China National Knowledge Infrastructure), Centre for Agriculture and Biosciences International (CABI), Cite Factor, EBSCO A-Z, Ex-Libris, Hamdard University, Journal TOCs, JournalSeek, Journal Citation Reports, Open J Gate, Publons, Proquest Summons, Refseek, Secret Search Engine Labs, Sherpa Romeo, SCOPUS, Science Citation Index Expanded, SJR (Scimago Journal and Country Rank), UGC (University Grants Commission), Ulrich Periodical Directory, World Cat - OCLC and Web of Science. Journal Ethics The Indian Journal of Pharmacy started in 1939 as "a quarterly journal devoted to the Science and practice of Pharmacy in all its branches". The Chief Editor and the main guiding force behind the 'Journal' was Prof. M. L. Schroff, Head of the Department of Pharmaceutics, Benaras Hindu University, Benaras. Owing to various difficulties experienced in publishing the 'Journal" at Benaras, the Council of IPA decided in 1946 to entrust the task to its Bombay Branch, and to transfer the editorial and publication offices to Bombay. Prof. M. L. Khorana, Head of the Pharmaceuticals Section, Department of Chemical Technology, Bombay University was requested to take the Editorship. In 1949 it was decided to publish this journal bi-monthly instead of quarterly. Soon after from January 1950 this journal started coming out as a monthly periodical. While Mr. S. P. Mukherji worked as Assistant Editor from 1946 to 1952, in May 1950 Mr. N. S. Bhunvara joined as the second Assistant Editor. The Headquarters of the IPA was shifted to Bombay with effect from 1st January 1953 and this helped considerably the publication of this journal and its circulation to members. Prof. Khorana resigned as Editor of the journal with effect from 1 January 1954 and Dr. G. B. Ramasarma succeeded him as the Editor and Mr. A. I. Mehta and Dr. R. S. Baichwal joined as Assistant Editors. In 1955 July, the journal’s office together with those of the Association and the Bombay State Branch was shifted from U. D. C. T., Matunga to Kalam Kutir 213-219, Frere Road, Bombay - 1. From 1959, Mr. L. S. Patel joined as the third Assistant Editor. In 1963, the Indian Journal of Pharmacy celebrated its Silver Jubilee. A detailed history of the Journal was published in the journal (IJP, 1963, 25, 8-17). The year 1969 represented an important milestone in the history of IJP. From this year it changed its character from that of “the official publication” of the IPA to that of "the official scientific publication" of the association. Publication of professional and other general articles and Association News was taken over by a new monthly periodical called "Pharma Times" with Mr. A. I. Mehta as its Editor. The IJP became an exclusively scientific journal and the frequency of its publication was reduced to that of a bimonthly. Dr. R. S. Baichwal took over as the first Editor of this Journal. In 1979 the name of IJP was expanded to the 'Indian Journal of Pharmaceutical Sciences'. In 1986, Dr. C. L. Kaul joined as the Associated Editor, went on to become the Editor in 1992, and continued till 1996. Dr. Rao V. S. V. Vadlamudi joined the editorial team as the Associate Editor in 1994, became the Editor in 1996, and continued till 2013. Dr. Divakar Goli is elected as the Editor for IJPS in 2014 and continues till date. The journal changed its get-up in 2000 and became online in 2006 with the journal website www.ijpsonline.com. Currently it is available as a print version with a circulation of about 800 and also available online. Indian Pharmaceutical Association The Indian Pharmaceutical Association (IPA) is the oldest premier association of pharmaceutical professionals in India, with a member base of over 13,000, spread across the length and breadth of the country. IPA operates in India through 20 state branches and more than 45 local branches. The members represent various facets of pharmaceutical profession viz., industry, regulatory, community and hospital pharmacy practices, and education. As a member of the Drug Technical Advisory Board, India, IPA is actively involved in advising the government on matters of professional importance. IPA is affiliated with international pharma associations like FIP, FAPA, CPA, AAPS, AAiPS, IPSF and is working with international bodies such as WHO and WHPA for carrying out various collaborative professional activities that include organizing training programs for professionals from industry, academics, regulatory and practice. IPA makes representations to the authorities on matters of professional interest and works constantly towards upgrading the standards of pharmacy professional services offered by the pharmacists. IPA’s major objective is to position pharmacists as one of the important healthcare providers in our country. The IPA is committed to promote the highest professional and ethical standards of pharmacy, focus the image of pharmacists as competent healthcare professionals, sensitize the community, government, and others on vital professional issues and support pharmaceutical education and sciences in all aspects. RG Journal Impact: 0.15 * *This value is calculated using ResearchGate data and is based on average citation counts from work published in this journal. The data used in the calculation may not be exhaustive. RG Journal impact history 2020 Available summer 2021 2018 / 2019 0.15 2017 0.50 2016 0.35 2015 1.21 2014 1.04 2013 0.46 2012 0.82 2011 0.05 2010 0.22 2009 0.69 2008 0.56 2007 0.28 2006 0.55 2005 0.14 2002 0.19 The Indian Journal of Pharmacy Details Indian Journal of Pharmacy H Index: 50 Publication Type: Journals Coverage: 1978-ongoing Subject Area and Category Pharmacology, Toxicology and Pharmaceutics, Pharmaceutical Science Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Pharmacology and Therapeutics, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Pharmacovigilance, Pharmacoepidemiology, Pharmacoeconomics, Drug Information, Patient Counselling, Adverse Drug Reactions Monitoring, Medication Errors, Medication Optimization, Medication Therapy Management, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest
Indian journal of pharmaceutical sciences Impact Factor 2024-2025 - ResearchHelpDesk - Indian Journal of Pharmaceutical Sciences (0250-474X), is the official scientific publication of the Indian Pharmaceutical Association. It started in 1939 as the Indian Journal of Pharmacy. the journal is published Bimonthly. Abstracting and Indexing Information The journal is included in the following Abstracting / Indexing services: Biosis Preview, Chemical Abstract Service (CAS), CNKI (China National Knowledge Infrastructure), Centre for Agriculture and Biosciences International (CABI), Cite Factor, EBSCO A-Z, Ex-Libris, Hamdard University, Journal TOCs, JournalSeek, Journal Citation Reports, Open J Gate, Publons, Proquest Summons, Refseek, Secret Search Engine Labs, Sherpa Romeo, SCOPUS, Science Citation Index Expanded, SJR (Scimago Journal and Country Rank), UGC (University Grants Commission), Ulrich Periodical Directory, World Cat - OCLC and Web of Science. Journal Ethics The Indian Journal of Pharmacy started in 1939 as "a quarterly journal devoted to the Science and practice of Pharmacy in all its branches". The Chief Editor and the main guiding force behind the 'Journal' was Prof. M. L. Schroff, Head of the Department of Pharmaceutics, Benaras Hindu University, Benaras. Owing to various difficulties experienced in publishing the 'Journal" at Benaras, the Council of IPA decided in 1946 to entrust the task to its Bombay Branch, and to transfer the editorial and publication offices to Bombay. Prof. M. L. Khorana, Head of the Pharmaceuticals Section, Department of Chemical Technology, Bombay University was requested to take the Editorship. In 1949 it was decided to publish this journal bi-monthly instead of quarterly. Soon after from January 1950 this journal started coming out as a monthly periodical. While Mr. S. P. Mukherji worked as Assistant Editor from 1946 to 1952, in May 1950 Mr. N. S. Bhunvara joined as the second Assistant Editor. The Headquarters of the IPA was shifted to Bombay with effect from 1st January 1953 and this helped considerably the publication of this journal and its circulation to members. Prof. Khorana resigned as Editor of the journal with effect from 1 January 1954 and Dr. G. B. Ramasarma succeeded him as the Editor and Mr. A. I. Mehta and Dr. R. S. Baichwal joined as Assistant Editors. In 1955 July, the journal’s office together with those of the Association and the Bombay State Branch was shifted from U. D. C. T., Matunga to Kalam Kutir 213-219, Frere Road, Bombay - 1. From 1959, Mr. L. S. Patel joined as the third Assistant Editor. In 1963, the Indian Journal of Pharmacy celebrated its Silver Jubilee. A detailed history of the Journal was published in the journal (IJP, 1963, 25, 8-17). The year 1969 represented an important milestone in the history of IJP. From this year it changed its character from that of “the official publication” of the IPA to that of "the official scientific publication" of the association. Publication of professional and other general articles and Association News was taken over by a new monthly periodical called "Pharma Times" with Mr. A. I. Mehta as its Editor. The IJP became an exclusively scientific journal and the frequency of its publication was reduced to that of a bimonthly. Dr. R. S. Baichwal took over as the first Editor of this Journal. In 1979 the name of IJP was expanded to the 'Indian Journal of Pharmaceutical Sciences'. In 1986, Dr. C. L. Kaul joined as the Associated Editor, went on to become the Editor in 1992, and continued till 1996. Dr. Rao V. S. V. Vadlamudi joined the editorial team as the Associate Editor in 1994, became the Editor in 1996, and continued till 2013. Dr. Divakar Goli is elected as the Editor for IJPS in 2014 and continues till date. The journal changed its get-up in 2000 and became online in 2006 with the journal website www.ijpsonline.com. Currently it is available as a print version with a circulation of about 800 and also available online. Indian Pharmaceutical Association The Indian Pharmaceutical Association (IPA) is the oldest premier association of pharmaceutical professionals in India, with a member base of over 13,000, spread across the length and breadth of the country. IPA operates in India through 20 state branches and more than 45 local branches. The members represent various facets of pharmaceutical profession viz., industry, regulatory, community and hospital pharmacy practices, and education. As a member of the Drug Technical Advisory Board, India, IPA is actively involved in advising the government on matters of professional importance. IPA is affiliated with international pharma associations like FIP, FAPA, CPA, AAPS, AAiPS, IPSF and is working with international bodies such as WHO and WHPA for carrying out various collaborative professional activities that include organizing training programs for professionals from industry, academics, regulatory and practice. IPA makes representations to the authorities on matters of professional interest and works constantly towards upgrading the standards of pharmacy professional services offered by the pharmacists. IPA’s major objective is to position pharmacists as one of the important healthcare providers in our country. The IPA is committed to promote the highest professional and ethical standards of pharmacy, focus the image of pharmacists as competent healthcare professionals, sensitize the community, government, and others on vital professional issues and support pharmaceutical education and sciences in all aspects. RG Journal Impact: 0.15 * *This value is calculated using ResearchGate data and is based on average citation counts from work published in this journal. The data used in the calculation may not be exhaustive. RG Journal impact history 2020 Available summer 2021 2018 / 2019 0.15 2017 0.50 2016 0.35 2015 1.21 2014 1.04 2013 0.46 2012 0.82 2011 0.05 2010 0.22 2009 0.69 2008 0.56 2007 0.28 2006 0.55 2005 0.14 2002 0.19 The Indian Journal of Pharmacy Details Indian Journal of Pharmacy H Index: 50 Publication Type: Journals Coverage: 1978-ongoing Subject Area and Category Pharmacology, Toxicology and Pharmaceutics, Pharmaceutical Science Pharmaceutical Technology, Pharmaceutics, Biopharmaceutics, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Pharmacology and Therapeutics, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Pharmacovigilance, Pharmacoepidemiology, Pharmacoeconomics, Drug Information, Patient Counselling, Adverse Drug Reactions Monitoring, Medication Errors, Medication Optimization, Medication Therapy Management, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Longitudinal behavior of Altmetrics in Orthodontic research: Analysis of the orthodontic journals indexed in the journal citation reports from 2014 to 2018 A first search was carried out, in December 2019, in the inCites JCR database to select orthodontic journals that were included in the category of dentistry, oral surgery, and medicine of the JCR during the period from 2014 to 2018. The online interest generated by the orthodontic research outputs, was observed and tracked through the Dimensions free app https://app.dimensions.ai/discover/publication in the Dimensions database. The search was limited to the nine journals listed in the JCR in 2018, which were the American Journal of Orthodontics & Dentofacial Orthopedics (AJODO), The Angle Orthodontist, The European Journal of Orthodontics (EJO), Progress in Orthodontics, Korean Journal of Orthodontics (KJO), Orthodontics & Craniofacial Research (OCR), Journal of Orofacial Orthopedics/Fortschritte der Kieferorthopädie, Seminars in Orthodontics, and the Australian Orthodontic Journal. The Dimension App was used to carry out the search and the following filters were applied: publication year (2018 or 2017 or 2016 or 2015 or 2014); source title (American Journal of Orthodontics & Dentofacial Orthopedics OR The European Journal of Orthodontics OR The Angle Orthodontist OR Korean Journal of Orthodontics OR Orthodontics & Craniofacial Research OR Journal of Orofacial Orthopedics/Fortschritte der Kieferorthopädie OR Progress in Orthodontics OR Seminars in Orthodontics OR the Australian Orthodontic Journal). Data were exported to an Excel data sheet (Microsoft Office for Mac version 16.43). In December 2021 a second search was performed on the Dimension Web app by the members of the research team introducing the DOI or the article title of the 3678 items included in the 2019 sample. Here are presented the data related to the 3678 analysed Items divided per journal, the number of altmetrics mentions is presented for each item at both time intervals as well as their change over the studied period.
Not seeing a result you expected?
Learn how you can add new datasets to our index.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Background: Artificial intelligence (AI) is used in ophthalmological disease screening and diagnostics, medical image diagnostics, and predicting late-disease progression rates. We reviewed all AI publications associated with macular edema (ME) research Between 2011 and 2022 and performed modeling, quantitative, and qualitative investigations.Methods: On 1st February 2023, we screened the Web of Science Core Collection for AI applications related to ME, from which 297 studies were identified and analyzed (2011–2022). We collected information on: publications, institutions, country/region, keywords, journal name, references, and research hotspots. Literature clustering networks and Frontier knowledge bases were investigated using bibliometrix-BiblioShiny, VOSviewer, and CiteSpace bibliometric platforms. We used the R “bibliometrix” package to synopsize our observations, enumerate keywords, visualize collaboration networks between countries/regions, and generate a topic trends plot. VOSviewer was used to examine cooperation between institutions and identify citation relationships between journals. We used CiteSpace to identify clustering keywords over the timeline and identify keywords with the strongest citation bursts.Results: In total, 47 countries published AI studies related to ME; the United States had the highest H-index, thus the greatest influence. China and the United States cooperated most closely between all countries. Also, 613 institutions generated publications - the Medical University of Vienna had the highest number of studies. This publication record and H-index meant the university was the most influential in the ME field. Reference clusters were also categorized into 10 headings: retinal Optical Coherence Tomography (OCT) fluid detection, convolutional network models, deep learning (DL)-based single-shot predictions, retinal vascular disease, diabetic retinopathy (DR), convolutional neural networks (CNNs), automated macular pathology diagnosis, dry age-related macular degeneration (DARMD), class weight, and advanced DL architecture systems. Frontier keywords were represented by diabetic macular edema (DME) (2021–2022).Conclusion: Our review of the AI-related ME literature was comprehensive, systematic, and objective, and identified future trends and current hotspots. With increased DL outputs, the ME research focus has gradually shifted from manual ME examinations to automatic ME detection and associated symptoms. In this review, we present a comprehensive and dynamic overview of AI in ME and identify future research areas.